Literature DB >> 10327206

Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease.

O Murayama1, T Tomita, N Nihonmatsu, M Murayama, X Sun, T Honda, T Iwatsubo, A Takashima.   

Abstract

Families bearing mutations in the presenilin 1 (PS1) gene develop early onset familial Alzheimer's disease (FAD). Further, some PS1 mutants enhance secretion of the longer form of amyloid beta protein (Abeta42). We constructed cDNAs encoding human PS1 harboring 28 FAD-linked mutations, and examined the effects of the expressed PS1 mutants on Abeta42 secretion in beta amyloid precursor producing COS-1 cells. All the mutants significantly enhanced the ratio of Abeta42 to total Abeta compared with wild-type PS1. However, the increase in Abeta42 ratio in cells with each PS1 mutation did not correlate with the reported age of onset of FAD caused by that mutation. These results suggest that increased Abeta42 secretion is important for the development of Alzheimer's disease (AD), but may not be the only factor contributing to the onset of AD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10327206     DOI: 10.1016/s0304-3940(99)00187-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  28 in total

1.  Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.

Authors:  D M Mann; S M Pickering-Brown; A Takeuchi; T Iwatsubo
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

2.  Familial cases presenting very early onset autosomal dominant Alzheimer's disease with I143T in presenilin-1 gene: implication for genotype-phenotype correlation.

Authors:  Noritoshi Arai; Atsushi Kishino; Yuji Takahashi; Daiji Morita; Koichiro Nakamura; Takahiro Yokoyama; Tomoji Watanabe; Masayoshi Ida; Jun Goto; Shoji Tsuji
Journal:  Neurogenetics       Date:  2007-10-30       Impact factor: 2.660

3.  Presenilin 1 mutations influence processing and trafficking of the ApoE receptor apoER2.

Authors:  Wei Wang; Andrea M Moerman-Herzog; Arthur Slaton; Steven W Barger
Journal:  Neurobiol Aging       Date:  2016-10-11       Impact factor: 4.673

4.  Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.

Authors:  R Siman; A G Reaume; M J Savage; S Trusko; Y G Lin; R W Scott; D G Flood
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

5.  Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production.

Authors:  Tobias Moehlmann; Edith Winkler; Xuefeng Xia; Dieter Edbauer; Jill Murrell; Anja Capell; Christoph Kaether; Hui Zheng; Bernardino Ghetti; Christian Haass; Harald Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

Review 6.  Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development.

Authors:  Joanna L Jankowsky; Alena Savonenko; Gabriele Schilling; Jiou Wang; Guilian Xu; David R Borchelt
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

7.  Presenilin 1 interacts with acetylcholinesterase and alters its enzymatic activity and glycosylation.

Authors:  María-Ximena Silveyra; Geneviève Evin; María-Fernanda Montenegro; Cecilio J Vidal; Salvador Martínez; Janetta G Culvenor; Javier Sáez-Valero
Journal:  Mol Cell Biol       Date:  2008-02-25       Impact factor: 4.272

8.  PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations.

Authors:  Lia Baki; Junichi Shioi; Paul Wen; Zhiping Shao; Alexander Schwarzman; Miguel Gama-Sosa; Rachael Neve; Nikolaos K Robakis
Journal:  EMBO J       Date:  2004-06-10       Impact factor: 11.598

9.  Neuronal cell death in Alzheimer's disease and a neuroprotective factor, humanin.

Authors:  Takako Niikura; Hirohisa Tajima; Yoshiko Kita
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

10.  Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling.

Authors:  Anastasios Georgakopoulos; Claudia Litterst; Enrico Ghersi; Lia Baki; ChiJie Xu; Geo Serban; Nikolaos K Robakis
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.